Starpharma
Starpharma is a leading developer of dendrimer products for pharmaceutical and life science applications, known for its DEP® drug delivery platform and products like VIRALEZE™ and VivaGel® BV.
Company Overview
Starpharma is a world leader in the development of dendrimer products for pharmaceutical, life science, and other applications. The company leverages proprietary polymers known as dendrimers, which are nanoscale molecules that are synthetically manufactured with precision. Starpharma's portfolio includes clinical-stage oncology products and marketed products such as VIRALEZE™ and VivaGel® BV. The company employs its DEP® drug delivery platform to enhance the effectiveness of therapies and reduce drug-related toxicities.
Products
Starpharma's product portfolio includes VIRALEZE™ and VivaGel® BV. VIRALEZE™ is a topical nasal spray registered in more than 35 countries. VivaGel® BV is a non-antibiotic vaginal gel registered in more than 50 countries. In addition, Starpharma's portfolio features multiple clinical-stage oncology products primarily focused on enhancing treatment efficacy through its DEP® drug delivery platform.
Partnerships
Starpharma has established partnerships with several international biopharmaceutical companies, including AstraZeneca, MSD, and Chase Sun. These collaborations are focused on leveraging Starpharma's dendrimer technology and DEP® drug delivery platform to enhance the effectiveness of various therapeutic products. These strategic partnerships aim to bring innovative treatments to market more efficiently and effectively.
Sustainability and Certification
Starpharma publishes an annual Environment, Social and Governance (ESG) Report to outline its commitment to sustainability and responsible business practices. The company has also achieved the Great Place to Work® certification for 2023-24 in the small business category, demonstrating its commitment to fostering a positive and productive workplace environment.
Innovative Technologies
Starpharma utilizes innovative technologies such as dendrimers and the DEP® drug delivery platform. Dendrimers are nanoscale, synthetically manufactured molecules known for their precision. The DEP® platform is designed to increase the efficacy of treatments and reduce drug-related toxicities, making it a significant advancement in pharmaceutical delivery systems.